Private Capital Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Private Capital Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-128,377	Closed	-$2.62M	–	113
2015 Q4	$2.62M	Sell	128,377 -294,380	-70%	-$4.54M	1.13%	35
2015 Q3	$5.55M	Buy	422,757 +25,000	+6%	+$415K	2.32%	11
2015 Q2	$6.1M	Sell	397,757 -125	-0%	-$2.4K	1.99%	9
2015 Q1	$7.95M	Buy	397,882 +24,000	+6%	+$537K	2.89%	2
2014 Q4	$7.86M	Buy	373,882 +94,579	+34%	+$1.93M	2.96%	2
2014 Q3	$5.2M	Buy	279,303 +104,712	+60%	+$1.9M	1.68%	18
2014 Q2	$4.03M	Buy	+174,591	New	+$3.08M	1.3%	36

Other funds holding AGTC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Private Capital Advisors's AGTC Position: Q1 2016 in Review

Private Capital Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2016, closing a stake of 128,377 shares — an estimated $2.62M sold.

Private Capital Advisors first reported a position in AGTC in Q2 2014 and held it in 7 quarters. The position peaked at $7.95M in Q1 2015. 90 funds tracked by Wall St. Rank hold AGTC as of Q1 2016.

Private Capital Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q1 2016 after selling out during the quarter.
Private Capital Advisors sold 128,377 Applied Genetic Technologies Corporation shares in Q1 2016, an estimated $2.62M.
Private Capital Advisors first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 7 quarters.
Private Capital Advisors's Applied Genetic Technologies Corporation position peaked at $7.95M in Q1 2015.
90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2016.

Based on Private Capital Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.